Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q17142127> ?p ?o }
Showing triples 1 to 35 of
35
with 100 triples per page.
- Q17142127 subject Q6353443.
- Q17142127 subject Q8760145.
- Q17142127 subject Q8806853.
- Q17142127 abstract "Pernix Therapeutics (NASDAQ: PTX) is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and psychiatry, and has an interest in expanding into additional specialty segments. The Company promotes its branded products to physicians through its Pernix sales force, uses contracted sales organizations to market its non-core, cough and cold products, and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceutical, LLC and Cypress Pharmaceuticals, Inc.".
- Q17142127 foundingYear "1996".
- Q17142127 keyPerson Q140686.
- Q17142127 keyPerson Q484876.
- Q17142127 locationCountry Q30.
- Q17142127 type Q891723.
- Q17142127 wikiPageExternalLink www.pernixtx.com.
- Q17142127 wikiPageWikiLink Q140686.
- Q17142127 wikiPageWikiLink Q30.
- Q17142127 wikiPageWikiLink Q484876.
- Q17142127 wikiPageWikiLink Q6353443.
- Q17142127 wikiPageWikiLink Q8760145.
- Q17142127 wikiPageWikiLink Q8806853.
- Q17142127 wikiPageWikiLink Q891723.
- Q17142127 foundation "1996".
- Q17142127 keyPeople ", Sanjay Patel, Chief Financial Officer".
- Q17142127 keyPeople "Douglas Drysdale".
- Q17142127 locationCountry Q30.
- Q17142127 name "Pernix Therapeutics Holdings".
- Q17142127 type Q891723.
- Q17142127 type Organization.
- Q17142127 type Agent.
- Q17142127 type Company.
- Q17142127 type Organisation.
- Q17142127 type Agent.
- Q17142127 type SocialPerson.
- Q17142127 type Thing.
- Q17142127 type Q43229.
- Q17142127 comment "Pernix Therapeutics (NASDAQ: PTX) is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and psychiatry, and has an interest in expanding into additional specialty segments.".
- Q17142127 label "Pernix Therapeutics Holdings".
- Q17142127 homepage www.pernixtx.com.
- Q17142127 name "Pernix Therapeutics Holdings".